What is the global market size of Contrast Agents Market?

Global Contrast Agents Market size was valued at USD 5.08 billion in 2021 and is poised to grow from USD 5.22 billion in 2022 to USD 6.47 billion by 2030, growing at a CAGR of 2.71% in the forecast period (2023-2030).

Contrast Agents Market Size, Share, Growth Analysis, By Application(Hospitals, Clinics), By Product(Iodinated Contrast Media, Microbubble Contrast Media), By Modality(Ultrasound, X-ray/CT), By Region - Industry Forecast 2025-2032

Report ID: SQMIG15A2297 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 87 | Figures: 72

Contrast Agents Market Insights

Contrast Agents Market size was valued at USD 5.36 Billion in 2023 and is poised to grow from USD 5.51 Billion in 2024 to USD 6.82 Billion by 2032, growing at a CAGR of 2.71% during the forecast period (2025-2032).

The rise in complex comorbidities and chronic illnesses has prompted a surge in diagnostic imaging procedures such as ultrasound, X-rays, and advanced technologies such as MRI and CT scans. A significant development occurred in September 2022 with the U.S. FDA's approval of Gadopiclenol, an MRI contrast agent designed with high relativity and a reduced dosage of gadolinium. This approval marks a pivotal step in enhancing imaging precision while prioritizing patient safety, especially for adults and pediatric patients aged two years and above. Gadopiclenol's lower gadolinium dosage aligns with the imperative to minimize potential risks associated with contrast agents, signaling a promising advancement in diagnostic imaging for a diverse range of healthcare needs.

Contrast Agents Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The competitive environment of the global contrast agents market is characterized by a dynamic interplay of key players and evolving strategies within the food processing industry. Innovation is a key competitive factor. smaller and niche players are making a notable impact by focusing on specialized solutions and offering customizable blends to cater to specific meat processing needs. This diversity within the market allows food processors to select tailored solutions that align with their specific requirements. 'Bayer AG', 'General Electric Company', 'Guerbet', 'Bracco Diagnostic, Inc.', 'Nano Therapeutics Pvt. Ltd.', 'Lantheus Medical Imaging, Inc.', 'iMax', 'Trivitron Healthcare', 'GE Healthcare', 'Hengrui Medicine', 'YRPG', 'BeiLu Pharma', 'J.B. Chemicals and Pharmaceuticals Ltd.', 'Unijules Life Sciences Ltd.', 'SANOCHEMIA Pharmazeutika GmbH', 'Taejoon Pharm'

The evolving acceptance of image-guided surgeries (IGS) marks a significant trend in the medical landscape. These procedures, increasingly embraced over time, serve a dual purpose, enabling both diagnosis and treatment across various medical conditions. As the demand escalates for precise, real-time imaging enhancements during surgical interventions, the necessity emerges for novel approaches in data acquisition, processing, and display, coupled with a comprehensive understanding of imaging processes and their therapeutic applications.

The prevalence of multiple chronic conditions within the adult population, particularly those aged 65 and above, is a pressing concern in healthcare. As highlighted by the National Council on Aging, nearly 80% of individuals in this age group grapple with at least one chronic condition. Furthermore, approximately 70% of Medicare beneficiaries within this demographic contend with two or more chronic health issues, underscoring the complexity and challenges of managing multiple comorbidities simultaneously. Projections indicate a significant demographic shift, with an estimated 77.0 million individuals aged 65 and above in the United States by 2034.

North America emerged as the predominant force in the market, commanding the largest share, accounting for approximately 36.18%. This stronghold owes much to strategic maneuvers executed by major manufacturers, focusing on specialized patient subsets, poised to drive accelerated growth within the industry. Notable market players such as Bayer, GE Healthcare, Guerbet, Lantheus, and Bracco Diagnostics play pivotal roles in shaping this landscape.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Contrast Agents Market Size, Share, Growth Analysis, By Application(Hospitals, Clinics), By Product(Iodinated Contrast Media, Microbubble Contrast Media), By Modality(Ultrasound, X-ray/CT), By Region - Industry Forecast 2025-2032

Contrast Agents Market Insights

Contrast Agents Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Contrast Agents Market?

Who are the key vendors in the Contrast Agents Market?

What is the key driver of Contrast Agents Market?

What is the key market trend for Contrast Agents Market?

Which region accounted for the largest share in Contrast Agents Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300